NCT04478357 - BIOEQUIVALENCE STUDY IN HEALTHY PARTICIPANTS COMPARING 4 MG AND 8 MG FESOTERODINE EXTENDED-RELEASE TABLETS (TOVIAZ™), MANUFACTURED AT ZWICKAU VERSUS FREIBURG | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 12, 2019

Primary Completion Date

November 12, 2020

Study Completion Date

November 12, 2020

Conditions

Neurogenic Detrusor Overactivity

Interventions

DRUG

4 mg Fesoterodine ER tablet from Zwickau

Manufactured at Zwickau

DRUG

4 mg fesoterodine ER tablet from Freiburg

Manufactured at Freiburg

DRUG

8 mg fesoterodine ER tablet from Zwickau

Manufactured at Zwickau

DRUG

8 mg fesoterodine ER tablet from Freiburg

Manufactured at Freiburg

Trial Locations (1)

Brussels Clinical Research Unit, Brussels